Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors
Authors:
- Torsak BunupuradahTBTorsak Bunupuradah
- Sunee SirivichayakulSSSunee Sirivichayakul
- Chitsanu PancharoenCPChitsanu Pancharoen
- Thanyawee PuthanakitTPThanyawee Puthanakit
- Stephen J. KerrSKStephen J. Kerr
- Kiat RuxrungthamKRKiat Ruxrungtham
- Bernard HirschelBHBernard Hirschel
- Jintanat AnanworanichJAJintanat Ananworanich
- 25 August 2009
- journal article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 14 (4) , e311-e316
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Genotypic Susceptibility Scores and HIV Type 1 RNA Responses in Treatment-Experienced Subjects with HIV Type 1 InfectionAIDS Research and Human Retroviruses, 2008
- Resistance to Dual Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with HIV Clade A/EClinical Infectious Diseases, 2005
- Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitorsAIDS, 2003
- Survey of Reverse Transcriptase from the Heterosexual Epidemic of Human Immunodeficiency Virus Type 1 CRF01_AE in Thailand from 1990 to 2000AIDS Research and Human Retroviruses, 2001
- Use of Genotypic Resistance Testing To Guide HIV Therapy: Clinical Impact and Cost-EffectivenessAnnals of Internal Medicine, 2001
- A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapyAIDS, 2000
- Factors associated with the successful modification of antiretroviral therapyAIDS, 2000